Sorainen has provided pro bono legal advice for Estonian health technology startup Antegenes on the possibilities of expanding to other countries.
"For example, the health startup was facing the question if and on what conditions other European Union member states can limit the use of genetic tests across national borders. We also analyzed issues regarding the protection of personal data," the firm informed.
Founded in 2018, Antegenes is an Estonian medical technology company, providing genetic tests designed to assess personal cancer risks.
The Sorainen team included Partner Mihkel Miidla, Senior Associate Lise-Lotte Laane, and Associate Liisa Kuuskmaa.
